Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Gisleskog et al (2021)
Nicotine replacement therapy versus control for smoking cessation
Individual Clinical
All Categories
Hartmann‐Boyce et al (2025)
Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: A review
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Le Houezec (2003)
Safety Profile of a Nicotine Lozenge Compared with That_x000D_of Nicotine Gum in Adult Smokers with Underlying Medical_x000D_Conditions: A 12-Week, Randomized, Open-Label Study
Individual Clinical
Safety
Adverse Effects
Marsh et al (2005)
Effects of nicotine administration via a sublingual tablet on arousal and verbal ability in non-smokers
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of Users
Neumann (2009)
Local Tolerance of a Sublingual Nicotine Tablet, an Open Single-Centre Study
Individual Clinical
Safety
Human Factors
Sand et al (2012)
Randomized Comparative Trial of Nicotine Polacrilex, a Transdermal Patch, Nasal Spray, and an Inhaler.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Hajek et al (1999)
Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review.
Individual Clinical
West and Shiffman (2001)
assessing the association Between Electronic Cigarette Use among Cannabis-Naive adolescents and Future Cannabis Use-Overlapping Substances.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Compton (2022)
The Immediate Physiologic Effects of Vaping on Pulmonary Perfusion Revealed at MRI.
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
Kligerman (2022)